AI assistant
Sending…
Editas Medicine, Inc. — Director's Dealing 2018
May 21, 2018
33260_dirs_2018-05-21_27deca4c-f795-4031-ab1c-d6cd03b82c01.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Editas Medicine, Inc. (EDIT)
CIK: 0001650664
Period of Report: 2018-05-17
Reporting Person: Hopfield Jessica (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-05-17 | Common Stock | P | 6700 | $37.2806 | Acquired | 6700 | Direct |
More from Editas Medicine, Inc.
Capital/Financing Update
2026
May 26
Capital/Financing Update
2026
May 26
Capital/Financing Update
2026
May 26
Share Issue/Capital Change
2026
May 26
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 14
Earnings Release
2026
May 5
Annual Report
2026
Apr 28
Regulatory Filings
2026
Apr 7
Legal Proceedings Report
2026
Mar 27